The 107th meeting of Enlistment Evaluation Committee (EEC), Division of Health and OTC, DRAP was held on 23rd May, 2022. The detail of applications which required further information /clarification and documentation is attached hereunder for information by all stakeholders.
Publications
Minutes of 320th Meeting of Registration Board held on 29th -31st August, 2022
The Drug Registration Board convened its 320th meeting on 29th – 31st August, 2022 in the Committee Room of Drug Regulatory Authority of Pakistan, G-9/4, Islamabad. The minutes of meeting are hereby circulated for information of all stakeholders.
Minutes of 287th Meeting of Central Licensing Board held on 24th June 2022
Decisions of 48th meeting of Medial Device Board (Deficiency letters)
National Essential Medicine Lists
Availability of essential medicines is one of the essential building blocks of healthcare system. Essential medicines are those which satisfy the primary healthcare need of the population. These are intended to be available within the context of functioning of health system at all times, in adequate amounts, in the appropriate dosage form with assured quality, and at a price that the individual and community can afford.
Careful selection of a limited range of essential medicines of high quality can provide better management towards judicious use of health resources.
National standard treatment guidelines navigate selection of essential medicine with the expectation to ensure their availability with reference to proper use of medicine within the healthcare system while reducing its cost.
National Essential Medicine List NEML is a critical document which provides and supports quality of health services across the country. The list is based on disease prevalence, evidence on efficacy and safety, and comparative cost-effectiveness and parameters adapted by W.H.O in its latest edition of Model List of Essential Medicines.
Health sector in general and Pharmaceutical sector in particular is expected to seriously consider adopting this list as a way forward to guide Provincial Governments in Medicine & Pharmaceutical sector policies, the determinants of medicines access and availability. The Provincial Governments can play a pivotal role to encourage procurement and supply chain management policies based on essential medicine concepts to promote rational use of scarce public resources. Drug Regulatory Authority is committed to make all efforts to improve patient care through availability of cost efficacious, safe & quality medicines availability in the country.

Current List
The current version, updated in October 2023 is based on the 23rd WHO Model List of Essential Medicines List (MLEM).
Previous Lists
Minutes of 317th Meeting of Registration Board held on 16th – 17th May, 2022.
The Drug Registration Board convened its 317th meeting on 16th- 17th May, 2022 in the Committee Room of Drug Regulatory Authority of Pakistan, G-9/4, Islamabad. The minutes of meeting are hereby circulated for information of all stakeholders.
Minutes of 286th Meeting of Central Licensing Board held on 11th May 2022
Decisions of 47th meeting of Medical Device Board Meeting; Deficiency letter
The Medical Device Board (MDB) of Drug Regulatory Authority of Pakistan in its 47th meeting has deferred the 271 applications of registration of medical devices due to various deficiencies / shortcomings in the applications dossiers. These applicants are requested to furnish the requisite information / documentations as directed by the Medical Device Board, in the below attachment.